These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2592694)

  • 1. AIDS therapy and the detection of adverse drug effects in dental practice.
    Arrowsmith JB
    J Am Dent Assoc; 1989 Nov; Suppl():46S-48S. PubMed ID: 2592694
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of AIDS and HIV-related conditions.
    Goldschmidt RH; Dong BJ
    J Am Board Fam Pract; 1991; 4(3):178-91. PubMed ID: 1828928
    [No Abstract]   [Full Text] [Related]  

  • 3. The tolerance for zidovudine plus thrice weekly or daily trimethoprim-sulfamethoxazole with and without leucovorin for primary prophylaxis in advanced HIV disease. California Collaborative Treatment Group.
    Bozzette SA; Forthal D; Sattler FR; Kemper C; Richman DD; Tilles JG; Leedom J; McCutchan JA
    Am J Med; 1995 Feb; 98(2):177-82. PubMed ID: 7847434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus infection in children.
    Hoernle EH; Reid TE
    Am J Health Syst Pharm; 1995 May; 52(9):961-79. PubMed ID: 7641035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epoetin alpha approved for anemic AIDS patients.
    J Am Osteopath Assoc; 1991 Jun; 91(6):538. PubMed ID: 1874651
    [No Abstract]   [Full Text] [Related]  

  • 6. AIDS: AZT for children in extended US trial.
    Lindley D
    Nature; 1989 Nov; 342(6245):10. PubMed ID: 2811993
    [No Abstract]   [Full Text] [Related]  

  • 7. Increase in trimethoprim-sulphamethoxazole (co-trimoxazole) resistance at Chris Hani Baragwanath Hospital, Soweto, in the AIDS era.
    Crewe-Brown HH; Reyneke MP; Khoosal M; Becker PJ; Karstaedt AS
    S Afr Med J; 2004 Jun; 94(6):440-2. PubMed ID: 15250455
    [No Abstract]   [Full Text] [Related]  

  • 8. [Double-blind dose-response study of zidovudine in AIDS and advanced HIV infection. Nordic Medical Research Councils' HIV Therapy Group].
    Ugeskr Laeger; 1993 Jan; 155(2):104-7. PubMed ID: 8421854
    [No Abstract]   [Full Text] [Related]  

  • 9. A new HIV/AIDS drug.
    J Ark Med Soc; 1996 Jan; 92(8):407. PubMed ID: 8582889
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of HIV infection with zidovudine. The good use of AZT].
    Régnier B
    Rev Prat; 1991 Sep; 41(19):1801-4. PubMed ID: 1925359
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug surveillance for adverse reactions in patients with human immunodeficiency virus infection].
    Valencia ME; Gil A; Lavilla P; Pintado V; López Dupla JM
    An Med Interna; 1990 Nov; 7(11):591-8. PubMed ID: 2103216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIDS, safety, and the drug approval process.
    Uzych L
    Am Pharm; 1991 Oct; NS31(10):44, 46. PubMed ID: 1957798
    [No Abstract]   [Full Text] [Related]  

  • 13. Desensitization to trimethoprim-sulfamethoxazole in patients infected with human immunodeficiency virus.
    Quirino T; Bonfanti P; Niero F; Rizzardini G; Iemoli E; Milazzo F
    Clin Infect Dis; 1996 Feb; 22(2):396. PubMed ID: 8838220
    [No Abstract]   [Full Text] [Related]  

  • 14. [Zidovudine and human immunodeficiency virus infection: when and how to initiate treatment].
    Corzo JE; Leal M
    Med Clin (Barc); 1991 Jun; 97(5):178-80. PubMed ID: 1921546
    [No Abstract]   [Full Text] [Related]  

  • 15. "Treating through" hypersensitivity to co-trimoxazole in AIDS patients.
    Putterman C; Rahav G; Shalit M; Rubinow A
    Lancet; 1990 Jul; 336(8706):52. PubMed ID: 1973231
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA Committee recommends clearance for HIVID combination therapy.
    AIDS Patient Care STDS; 1996 Jun; 10(3):186. PubMed ID: 11361630
    [No Abstract]   [Full Text] [Related]  

  • 17. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE; Keruly J; Richman DD; Moore RD
    Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug eruptions in HIV infection].
    Roujeau JC
    Presse Med; 1994 Jan; 23(3):111-2. PubMed ID: 8177841
    [No Abstract]   [Full Text] [Related]  

  • 19. Impairment of tritan colour vision after initiation of treatment with zidovudine in patients with HIV disease or AIDS.
    Geier SA; Held M; Bogner JR; Kronawitter U; Berninger T; Klauss V; Goebel FD
    Br J Ophthalmol; 1993 May; 77(5):315-6. PubMed ID: 8318471
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of AIDS on drug availability and accessibility.
    Gilmore N
    AIDS; 1991; 5 Suppl 2():S253-62. PubMed ID: 1845055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.